Registration number: 14630152

SIBANDA PHARMA LTD

Contents

Company Information	1
Balance Sheet	2 to 3
Notes to the Unaudited Financial Statements	2

SIBANDA PHARMA LTD

Company Information

Directors

Mr Rodwell Sibanda Vladimira Sibanda

Registered office

5 HOLLOWBREAD GARDENS SOUTHAMPTON SO3 18LY

Accountants

TAX LINK (CTA) LIMITED Chartered Accountants & Tax AdvisorsThe Long Lodge 265-269 Kingston Road Wimbledon London Wimbledon SW19 3NW

SIBANDA PHARMA LTD

(Registration number: 14630152)
Balance Sheet as at 31 August 2025

	2025 £	2024 £
Fixed assets	377,701	394,392
Current assets	202,461	181,090
Prepayments and accrued income	6,642	3,435
Creditors: Amounts falling due within one year	(382,859)	(222,400)
Net current liabilities	(173,756)	(37,875)
Total assets less current liabilities	203,945	356,517
Creditors: Amounts falling due after more than one year	(203,170)	(319,938)
Accruals and deferred income	-	(1,723)
	775	34,856
Capital and reserves	775	34,856

1	General information

The company is a private company limited by share capital, incorporated in England and wales .

The address of its registered office is:
5 HOLLOWBREAD GARDENS
SOUTHAMPTON
SO3 18LY

These financial statements were authorised for issue by the Board on 9 April 2026.

2	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 11 (2024 - 4).

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.

Approved and authorised by the Board on 9 April 2026 and signed on its behalf by:
 

SIBANDA PHARMA LTD

(Registration number: 14630152)
Balance Sheet as at 31 August 2025

......................................... Mr Rodwell Sibanda Director

......................................... Vladimira Sibanda Director